Overview

Corneal Thinning During Topical Bevacizumab Therapy

Status:
Withdrawn
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether topical bevacizumab is safe or not when used in corneal neovascularization for long term period.
Phase:
N/A
Details
Lead Sponsor:
Yonsei University
Treatments:
Bevacizumab